基于全科医疗人群的慢阻肺急性加重自然史研究
该研究基于英国临床实践研究数据链中99,574例慢阻肺患者,随访最长10年(平均4.9年),按基线期AECOPD次数和严重程度分组,发现约四分之一患者随访期间未发生急性加重,基线AECOPD次数可梯度预测长期AECOPD发生率,且次数越多、程度越重,死亡风险越高。
要点
- 约四分之一慢阻肺患者最长10年随访期间未发生急性加重。
- 基线一年内AECOPD次数可梯度预测长期AECOPD发生率。
- 中重度AECOPD次数越多、程度越重,死亡风险越高。
核心结论
- 很大比例慢阻肺患者在最长10年随访中不发生急性加重。
- 单一年份的AECOPD频率可预测长期AECOPD发生率。
- AECOPD频率和严重程度增加与死亡风险升高相关,强调预防AECOPD的重要性。
研究设计与样本
- 基于英国临床实践研究数据链(UK Clinical Practice Research Datalink)的回顾性队列研究。
- 纳入2004年1月1日至2015年3月31日期间99,574例慢阻肺患者。
- 基线期(随访第一年)按AECOPD次数和严重程度分组,随后随访最长10年(平均4.9年)。
- 中度AECOPD定义为院外管理,重度定义为需住院。
主要发现
- 约四分之一慢阻肺患者随访期间未发生急性加重。
- 与基线期无AECOPD相比,AECOPD次数梯度预测未来长期AECOPD发生率,1次事件HR为1.71(1.66-1.77),5次及以上HR为3.41(3.27-3.56)。
- 与基线期无AECOPD相比,2次及以上中度AECOPD与死亡风险梯度增加相关,2次中度AECOPD的HR为1.10(1.03-1.18),5次及以上中度AECOPD的HR为1.57(1.45-1.70)。
- 重度AECOPD与更高的死亡风险相关(HR为1.79;1.65-1.94)。
临床怎么用
- 可利用单一年份的AECOPD频率识别长期反复加重的高风险患者。
- 对频繁或重度AECOPD患者应加强预防策略以降低死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) are important adverse events in the natural history of chronic obstructive pulmonary disease (COPD). OBJECTIVES: To investigate the natural history of AECOPDs over 10 years of follow-up. METHODS: We identified 99,574 patients with COPD from January 1, 2004, to March 31, 2015, from the UK Clinical Practice Research Datalink. We defined moderate AECOPDs as those managed outside hospital and severe as those requiring hospitalization. During the baseline period (first year of follow-up), patients were grouped according to the number and severity of AECOPDs and then followed for a maximum of 10 years (mean, 4.9 yr). We investigated the effect of baseline AECOPD number and severity on risk of further events and death. MEASUREMENTS AND MAIN RESULTS: Around one-quarter of the patients with COPD did not exacerbate during follow-up. Compared with no AECOPDs in the baseline period, AECOPD number predicted the future long-term rate of AECOPDs in a graduated fashion, ranging from hazard ratio (HR) of 1.71 (1.66-1.77) for one event to HR of 3.41 (3.27-3.56) for five or more events. Two or more moderate AECOPDs were also associated with an increased risk of death in a graduated fashion, ranging from HR of 1.10 (1.03-1.18) for two moderate AECOPDs to HR of 1.57 (1.45-1.70) for five or more moderate AECOPDs, compared with those with no AECOPDs at baseline. Severe AECOPDs were associated with an even higher risk of death (HR, 1.79; 1.65-1.94). CONCLUSIONS: A large proportion of patients with COPD do not exacerbate over a maximum 10 years of follow-up. AECOPD frequency in a single year predicts long-term AECOPD rate. Increasing frequency and severity of AECOPDs is associated with risk of death and highlights the importance of preventing AECOPDs.
引用
- Rothnie KJ, Müllerová H, Smeeth L, et al. Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018. PMID: 29474094. doi:10.1164/rccm.201710-2029OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。